BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sposito C, Di Sandro S, Brunero F, Buscemi V, Battiston C, Lauterio A, Bongini M, De Carlis L, Mazzaferro V. Development of a prognostic scoring system for resectable hepatocellular carcinoma. World J Gastroenterol 2016; 22(36): 8194-8202 [PMID: 27688661 DOI: 10.3748/wjg.v22.i36.8194]
URL: https://www.wjgnet.com/1007-9327/full/v22/i36/8194.htm
Number Citing Articles
1
Angelo Castello, Egesta Lopci. Imaging HCC treated with radioembolization: review of the literature and clinical examples of choline PET utilityClinical and Translational Imaging 2020; 8(5): 377 doi: 10.1007/s40336-020-00384-y
2
Carlo Sposito, Michela Monteleone, Luca Aldrighetti, Umberto Cillo, Raffaele Dalla Valle, Alfredo Guglielmi, Giuseppe Maria Ettorre, Alessandro Ferrero, Fabrizio Di Benedetto, Giorgio Ettore Rossi, Luciano De Carlis, Felice Giuliante, Vincenzo Mazzaferro. Preoperative predictors of liver decompensation after mini-invasive liver resectionSurgical Endoscopy 2021; 35(2): 718 doi: 10.1007/s00464-020-07438-2
3
Hui-Chuan Sun, Lu Xie, Xin-Rong Yang, Wei Li, Jian Yu, Xiao-Dong Zhu, Yong Xia, Ti Zhang, Yang Xu, Bo Hu, Li-Ping Du, Ling-Yao Zeng, Jian Ouyang, Wei Zhang, Tian-Qiang Song, Qiang Li, Ying-Hong Shi, Jian Zhou, Shuang-Jian Qiu, Qian Liu, Yi-Xue Li, Zhao-You Tang, Yu Shyr, Feng Shen, Jia Fan. Shanghai ScoreChinese Medical Journal 2017; 130(22): 2650 doi: 10.4103/0366-6999.218019
4
Rokas Stulpinas, Dovile Zilenaite-Petrulaitiene, Allan Rasmusson, Aiste Gulla, Agne Grigonyte, Kestutis Strupas, Arvydas Laurinavicius. Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection SamplesCancers 2023; 15(2): 366 doi: 10.3390/cancers15020366
5
Berend R. Beumer, Stefan Buettner, Boris Galjart, Jeroen L.A. van Vugt, Robert A. de Man, Jan N.M. IJzermans, Bas Groot Koerkamp. Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patientsEuropean Journal of Surgical Oncology 2022; 48(3): 492 doi: 10.1016/j.ejso.2021.09.012
6
Ren-Cai Lu, Bo She, Wen-Tao Gao, Yun-Hai Ji, Dong-Dong Xu, Quan-Shi Wang, Shao-Bo Wang. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospectsWorld Journal of Gastroenterology 2019; 25(32): 4682-4695 doi: 10.3748/wjg.v25.i32.4682
7
Masatoshi Kudo. Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular CarcinomaLiver Cancer 2022; 11(5): 399 doi: 10.1159/000526163